Squadron Capital
Squadron Capital, founded in 2008 and based in Granby, Connecticut, is an investment firm that focuses on acquiring and investing in operating companies within the B2B, finance, and healthcare sectors in the United States and abroad. Unlike traditional private equity firms, Squadron operates as an acquisition vehicle funded by a Chicago-based trust, allowing it to be exceptionally well-capitalized and typically free from the need for debt financing. This financial strength enables Squadron to expedite its diligence process and move quickly to closing transactions. The firm primarily targets companies with revenues between $10 million and $100 million and is currently seeking offshore acquisition opportunities. Squadron Capital is committed to long-term investments and actively supports the leadership teams of its portfolio companies in executing their business plans, while maintaining a decentralized governance structure that empowers these leaders to manage and grow their companies.
Developer of nanotechnology products. The company's nanolayer gradient refractive index (GRIN) technology allows for the design and manufacture of lenses with greater electro-optical performance in visible to near-infrared applications at a fraction of the size, weight and volume of currently available complex lenses, enabling medical and commercial sectors to create desired spherical refractive index distributions within the lens.
Developer of an orthopedic implant technology designed to improve the preparation of the bone prior to implantation. The company's orthopedic implant technology provides cortical screws for surgical purposes in the areas of trauma, spine, and total joints, enabling healthcare providers to circumferentially interlock the implant to the bone and provide multi-planar load resistance.
Developer of nanotechnology products. The company's nanolayer gradient refractive index (GRIN) technology allows for the design and manufacture of lenses with greater electro-optical performance in visible to near-infrared applications at a fraction of the size, weight and volume of currently available complex lenses, enabling medical and commercial sectors to create desired spherical refractive index distributions within the lens.
Forum Plastics Inc. specializes in the design, engineering, and manufacturing of precision medical injection molds, serving a crucial role in the production of various minimally invasive surgical devices. The company offers a range of products, including molds, injection molds, insert molds, and micro molds, along with secondary services such as pad printing, project management, and supply chain management. Its products are integral to devices used in endoscopic procedures, vascular infusion systems, cardiac catheters, and women’s health applications, among others. Founded in 1980 and headquartered in Waterbury, Connecticut, Forum Plastics operates around the clock, emphasizing efficiency and quality in its manufacturing processes. The company is dedicated to supporting advancements in medical technology through its innovative molding solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.